- Corporate Officers - K
- Klassen Preston
Insider Trading History of Klassen Preston
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Klassen Preston since 2013.
This trader's CIK number is 1493056.
At the time of last reporting, Klassen Preston was the President & CEO of Metacrine, Inc.. (stock ticker symbol MTCR).
Also see all insider trading activities at Metacrine, Inc..
Note that in the past
Klassen Preston also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Arena Pharmaceuticals Inc (ARNA) by Klassen Preston
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | ARNA | 0 | $0 | 19,000 | $803,952 | 25,300 | $286,900 |
Yearly summary of insider trading at Orexigen Therapeutics, Inc. (OREX) by Klassen Preston
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | OREX | 0 | $0 | 100,000 | $717,351 | 100,000 | $165,999 |
Yearly summary of insider trading at Metacrine, Inc. (MTCR) by Klassen Preston
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | MTCR | 0 | $0 | 380,605 | $157,189 | 0 | $0 |
| 2022 | MTCR | 0 | $0 | 44,748 | $22,552 | 0 | $0 |
| 2021 | MTCR | 20,547 | $74,688 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Klassen Preston:
1. Arena Pharmaceuticals Inc (ARNA)
2. Orexigen Therapeutics, Inc. (OREX)
3. Metacrine, Inc. (MTCR)
Table 1. Insider trading of Arena Pharmaceuticals Inc (ARNA) by Klassen Preston
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-10-14 | ARNA | Option Ex | 6,300 | .00 | 0 |
| 2019-01-08 | ARNA | Option Ex | 3,000 | 15.10 | 45,300 |
| 2019-01-07 | ARNA | Sale | 16,000 | 42.00 | 671,952 |
| 2019-01-08 | ARNA | Sale | 3,000 | 44.00 | 132,000 |
| 2019-01-07 | ARNA | Option Ex | 16,000 | 15.10 | 241,600 |
Table 2. Insider trading of Orexigen Therapeutics, Inc. (OREX) by Klassen Preston
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-07-25 | OREX | Option Ex | 71,229 | 1.66 | 118,240 |
| 2013-07-25 | OREX | Sale | 71,229 | 7.16 | 509,999 |
| 2013-05-28 | OREX | Option Ex | 28,771 | 1.66 | 47,759 |
| 2013-05-28 | OREX | Sale | 28,771 | 7.21 | 207,352 |
Table 3. Insider trading of Metacrine, Inc. (MTCR) by Klassen Preston
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-01-26 | MTCR | Sale | 380,605 | .41 | 157,189 |
| 2022-04-19 | MTCR | Sale | 44,748 | .50 | 22,552 |
| 2021-05-20 | MTCR | Buy | 20,547 | 3.63 | 74,688 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Klassen Preston
(President & CEO of Metacrine, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.